Les syndromes myéloprolifératifs d'expression vasculaire à numération normale : comment les explorer ?

This development may lead to improved care for patients with thrombotic manifestations, normal blood cell counts, and a positive JAK2V617F mutation: multidisciplinary management, including regular hematological monitoring, could lead to the introduction of a cytoreductive treatment.